H.Res. 1176 · 117th Congress
Expressing support for the designation of June 19, 2022, as "World Sickle Cell Awareness Day" in order to…
Full title
Expressing support for the designation of June 19, 2022, as "World Sickle Cell Awareness Day" in order to increase public alertness across the United States and global community about sickle cell disease, the continued need for empirical research, early detection screenings for sickle cell trait carriers, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions related to sickle cell disease.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DavisSponsor6 cosponsors · 3 D, 3 R
6 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This resolution supports the goals and ideals of World Sickle Cell Awareness Day. Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.
What it does: CRS summary · Introduced in House · Jun 15, 2022
This resolution supports the goals and ideals of World Sickle Cell Awareness Day. Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Expressing support for the designation of June 19, 2022, as "World Sickle Cell Awareness Day" in order to increase public alertness across the United States and global community about sickle cell disease, the continued need for empirical research, early detection screenings for sickle cell trait carriers, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions related to sickle cell disease.
Latest action (Jun 15, 2022): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jun 15, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.